128 related articles for article (PubMed ID: 17570869)
1. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.
Anantharamaiah GM; Mishra VK; Garber DW; Datta G; Handattu SP; Palgunachari MN; Chaddha M; Navab M; Reddy ST; Segrest JP; Fogelman AM
J Lipid Res; 2007 Sep; 48(9):1915-23. PubMed ID: 17570869
[TBL] [Abstract][Full Text] [Related]
2. A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry.
Tubb MR; Silva RA; Fang J; Tso P; Davidson WS
J Biol Chem; 2008 Jun; 283(25):17314-23. PubMed ID: 18430727
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Vascular Inflammation by Apolipoprotein A-IV.
Shearston K; Tan JTM; Cochran BJ; Rye KA
Front Cardiovasc Med; 2022; 9():901408. PubMed ID: 35845068
[TBL] [Abstract][Full Text] [Related]
4. Combined transcriptomic and lipidomic analysis of D-4F ameliorating bleomycin-induced pulmonary fibrosis.
Xia Y; Cheng M; Hu Y; Li M; Shen L; Ji X; Cui X; Liu X; Wang W; Gao H
Ann Transl Med; 2021 Sep; 9(18):1424. PubMed ID: 34733976
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein Mimetic Peptide Inhibits Neutrophil-Driven Inflammatory Damage via Membrane Remodeling and Suppression of Cell Lysis.
Lee MW; Luo EW; Silvestre-Roig C; Srinivasan Y; Akabori K; Lemnitzer P; Schmidt NW; Lai GH; Santangelo CD; Soehnlein O; Wong GCL
ACS Nano; 2021 Oct; 15(10):15930-15939. PubMed ID: 34586780
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases.
Wolska A; Reimund M; Sviridov DO; Amar MJ; Remaley AT
Cells; 2021 Mar; 10(3):. PubMed ID: 33800446
[TBL] [Abstract][Full Text] [Related]
7. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-
Swaminathan SK; Zhou AL; Ahlschwede KM; Curran GL; Lowe VJ; Li L; Kandimalla KK
J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535
[TBL] [Abstract][Full Text] [Related]
8. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence.
Raut S; Garud A; Nagarajan B; Sabnis N; Remaley A; Fudala R; Gryczynski I; Gryczynski Z; Dzyuba SV; Borejdo J; Lacko A
J Pharmacol Exp Ther; 2020 Apr; 373(1):113-121. PubMed ID: 31941718
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.
McGrath KC; Li X; Twigg SM; Heather AK
PLoS One; 2020; 15(1):e0226931. PubMed ID: 31914125
[TBL] [Abstract][Full Text] [Related]
10. Lipid Profiles at Birth Predict Teacher-Rated Child Emotional and Social Development 5 Years Later.
Manczak EM; Gotlib IH
Psychol Sci; 2019 Dec; 30(12):1780-1789. PubMed ID: 31710576
[TBL] [Abstract][Full Text] [Related]
11. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
12. D-4F, an apolipoprotein A-I mimetic, suppresses IL-4 induced macrophage alternative activation and pro-fibrotic TGF-β1 expression.
Song X; Shi Y; You J; Wang Z; Xie L; Zhang C; Xiong J
Pharm Biol; 2019 Dec; 57(1):470-476. PubMed ID: 31335245
[No Abstract] [Full Text] [Related]
13. Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status.
Kumar MS
Front Nutr; 2019; 6():11. PubMed ID: 30834248
[TBL] [Abstract][Full Text] [Related]
14. Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys.
Bourdi M; Amar M; Remaley AT; Terse PS
Regul Toxicol Pharmacol; 2018 Dec; 100():59-67. PubMed ID: 30359697
[TBL] [Abstract][Full Text] [Related]
15. Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies.
Curcio CA
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD160-AMD181. PubMed ID: 30357336
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular Organization of Apolipoprotein-A-I-Derived Peptides within Disc-like Arrangements.
Salnikov ES; Anantharamaiah GM; Bechinger B
Biophys J; 2018 Aug; 115(3):467-477. PubMed ID: 30054032
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.
He D; Zhao M; Wu C; Zhang W; Niu C; Yu B; Jin J; Ji L; Willard B; Mathew AV; Chen YE; Pennathur S; Yin H; He Y; Pan B; Zheng L
Redox Biol; 2018 May; 15():228-242. PubMed ID: 29277016
[TBL] [Abstract][Full Text] [Related]
18. CD36 in chronic kidney disease: novel insights and therapeutic opportunities.
Yang X; Okamura DM; Lu X; Chen Y; Moorhead J; Varghese Z; Ruan XZ
Nat Rev Nephrol; 2017 Dec; 13(12):769-781. PubMed ID: 28919632
[TBL] [Abstract][Full Text] [Related]
19. The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.
Nowacki TM; Remaley AT; Bettenworth D; Eisenblätter M; Vowinkel T; Becker F; Vogl T; Roth J; Tietge UJ; Lügering A; Heidemann J; Nofer JR
Br J Pharmacol; 2016 Sep; 173(18):2780-92. PubMed ID: 27425846
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
